References
- Murphy G, Dawsey SM, Engels EA, et al. Cancer risk after pernicious anemia in the US elderly population. Clin Gastroenterol Hepatol. 2015;13:2282–2289.
- Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis-pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10:529–541.
- Park JY, Cornish TC, Lam-Himlin D, et al. Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting. Am J Surg Pathol. 2010;34:1591–1598.
- Miceli E, Lenti MV, Padula D, et al. Common features of patients with autoimmune atrophic gastritis. Clin Gastroenterol Hepatol. 2012;10:812–814.
- Carmel R. Prevalence of undiagnosed pernicious anemia in the elderly. Arch Intern Med. 1996;156:1097–1100.
- Xiao SD, Jiang SJ, Shi Y, et al. Pernicious anemia and type A atrophic gastritis in the Chinese. Chin Med J. 1990;103:192–196.
- Wun Chan JC, Yu Liu HS, Sang Kho BC, et al. Pernicious anemia in Chinese: a study of 181 patients in a Hong Kong hospital. Medicine. 2006;85:129–138.
- Yamada T, Ichikawa H. X-ray diagnosis of elevated lesions of the stomach. Radiology. 1974;110:79–83.
- Dixon MF, Genta RM, Yardley JH, et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–1181.
- Torbenson M, Abraham SC, Boitnott J, et al. Autoimmune Gastritis: distinct histological and immunohistochemical findings before complete loss of oxyntic glands. Mod Pathol. 2002;15:102–109.
- Pittman ME, Voltaggio L, Bhaijee F, et al. Autoimmune metaplastic atrophic gastritis: recognizing precursor lesions for appropriate patient evaluation. Am J Surg Pathol. 2015;39:1611–1620.
- Genta RM. Inflammatory disorders of the stomach. In: Odze RD, Goldblum JR, Crawford JM, editors. Surgical pathology of the GI tract, liver, biliary tract and pancreas. Philadelphia: Saunders; 2009. p. 157.
- Soykan I, Yakut M, Keskin O, et al. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion. 2012;86:20–26.
- Schade SG, Cohen RG, Conrad ME. The effect of hypochloric acid oniron absorption. N Engl J Med. 1968;279:621–624.
- Annibale B, Capurso G, Delle Fave G. The stomach and iron deficiency anaemia: a forgotten link. Dig Liver Dis. 2003;35:288–295.
- Van den Driessche A, Eenkhoorn V, Van Gaal L, et al. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review. Neth J Med. 2009;67:376–387.
- Coati I, Fassan M, Farinati F, et al. Autoimmune gastritis: Pathologist’s viewpoint. World J Gastroenterol. 2015;21:12179–12189.
- Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev. 2014;13:459–462.
- Lahner E, Centanni M, Agnello G, et al. Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis. Am J Med. 2008;121:136–141.
- Castoro C, Le Moli R, Arpi ML, et al. Association of autoimmune thyroid diseases, chronic atrophic gastritis and gastric carcinoid: experience from a single institution. J Endocrinol Invest. 2016;39:779–784.
- Valdes Socin H, Lutteri L, Cavalier E, et al. The thyrogastric syndrome: its effects on micronutriments and gastric tumorigenesis. Rev Med Liege. 2013;68:579–584.
- Mitchison HC, Bassendine MF, Hendrick A, et al. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis? Hepatology. 1986;6:1279–1284.
- Heathcote EJ. Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines. Hepatology. 2000;31:1005–1013.
- Saravanan R, Kamalaporn P, Streutker C, et al. Gastric polyp in pernicious anemia: an argument to remove even when biopsy shows hyperplasia. Endoscopy. 2008;40(Suppl. 2):E77–E78.
- Krasinskas AM, Abraham SC, Metz DC, et al. Oxyntic mucosa pseudopolyps: a presentation of atrophic autoimmune gastritis. Am J Surg Pathol. 2003;27:236–241.
- Tepeš B. Long-term acid inhibition: benefits and harms. Dig Dis. 2011;29:476–481.
- Rindi G, Fiocca R, Morocutti A, et al. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. Eur J Gastroenterol Hepatol. 2005;17:559–566.
- Declich P, Belloni J, Tavani E, et al. Fundic gland polyps and proton pump inhibitors: an obvious link, or an open question?. Hum Pathol. 2014;45:1122–1123.
- Zhang H, Jin Z, Ding S. Gastric calcifying fibrous tumor: a case of suspected immunoglobulin G4-related gastric disease. Saudi J Gastroenterol. 2015;21:423–426.
- Lahner E, Esposito G, Pilozzi E, et al. Gastric cancer in patients with type I gastric carcinoids. Gastric. Cancer. 2015;18:564–570.